Ovarian stimulation in women with high and low body mass index: GnRH agonist versus GnRH antagonist

Kumbak, Banu; Akbas, Hande; Sahin, Levent; Karlikaya, Guvenc; Karagozoglu, Hale; Kahraman, Semra
March 2010
Reproductive BioMedicine Online (Reproductive Healthcare Limited;Mar2010, Vol. 20 Issue 3, p314
Academic Journal
This study evaluated women with a high body mass index (BMI) (>40 kg/m²) and low BMI (<18 kg/m²) undergoing assisted reproduction treatment and determined whether the type of gonadotrophin-releasing hormone (GnRH) analogue used has an impact on cycle parameters and outcome. The study analysed 65 women with high BMI and 118 with low BMI. In the former group, polycystic ovarian syndrome was significantly more prevalent in the agonist long protocol (ALP) group (P = 0.01) and gonadotrophin consumption was lower, peak oestradiol concentrations and total number of oocytes retrieved were higher in the ALP group compared with the antagonist (ANT) group. Implantation rate (IR), pregnancy rate (PR) per embryo transfer and early pregnancy loss rate (EPLR) were similar in both stimulation groups, with overall rates of 21.6%, 55.4% and 44.4%, respectively. In women with low BMI, peak oestradiol concentrations, total oocytes retrieved, mature oocytes and transferred embryos were higher in the ALP group compared with ANT group. IR, PR/embryo transfer and EPLR were similar in both groups, with overall rates of 24.3%, 52.5% and 16.1%, respectively. In all patients, no difference was found between ALP and ANT protocols concerning treatment outcome. Contrary to the reasonable EPLR observed in women with low BMI, the high rate found in women with high BMI is remarkable.


Related Articles

  • ART, clinical: GnRH agonist/antagonist.  // Human Reproduction;Jul2007 Supplement 1, Vol. 22, pi120 

    The article presents abstracts on the use of gonadotropin-releasing hormone (GnRH) agonists and antagonists in assisted reproductive technology (ART), including the administration of gonadoliberine analogues (GnRH-a) to patients with Hodgkin lymphoma (HL) during chemotherapy and prevention of...

  • Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass index. Orvieto, Raoul; Nahum, Ravit; Meltcer, Simion; Homburg, Roy; Rabinson, Jacob; Anteby, Eyal Y.; Ashkenazi, Jacob // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Mar2009, Vol. 18 Issue 3, p333 

    In an attempt to examine whether body mass index (BMI) may influence IVF outcome in polycystic ovary syndrome (PCOS) patients undergoing ovarian stimulation with either gonadotrophin-releasing hormone (GnRH)-agonist (agonist group) or antagonist (antagonist group), 100 IVF cycles were studied:...

  • Comparing GnRH agonist long protocol and gnrh antagonist protocol in outcome the first cycle of ART. Firouzabadi, Razieh; Ahmadi, Shahnaz; Oskouian, Homa; Davar, Robab // Archives of Gynecology & Obstetrics;Jan2010, Vol. 281 Issue 1, p81 

    This prospective study evaluated the efficacy of gonadotropin-releasing hormone (GnRH) antagonist protocol in comparison with the GnRH agonist protocol in the first cycle of assisted reproductive technique (ART). We randomized 235 patients undergoing ART for the first time. The first group was...

  • Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS. Vrtačnik-Bokal, Eda; Klun, Irma Virant; Verdenik, Ivan // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jan2009, Vol. 18 Issue 1, p21 

    The aim of this study was to determine whether follicular oestradiol and vascular endothelial growth factor (VEGF) concentrations in women with polycystic ovarian syndrome (PCOS) differ according to the use of gonadotrophin-releasing hormone (GnRH) antagonists or GnRH agonists. Furthermore, the...

  • Comparison of GnRH agonists and antagonists in the outcome of IVF/ICSI in women with polycystic ovary syndrome. Zeinalzadeh, M.; Norani, N.; Esmaeilzadeh, S.; Yousefniapasha, Y.; Firoozpour, M.; Khafri, S. // Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p58 

    Introduction: To compare the outcome of using gonadotropin-releasing hormone (GnRH) antagonists versus agonists in women with polycystic ovary syndrome (PCOS) who underwent controlled ovarian hyper stimulation (COH) for assisted reproductive techniques (ART). Materials and Methods: A total of...

  • Effect of Combining Recombinant FSH with Recombinant LH on Oocyte and Embryo Quality in the GnRH Agonist Long and Antagonist Cycles. Kumbak, Banu; Kahraman, Semra // Journal of the Turkish-German Gynecological Association;Sep2008, Vol. 9 Issue 3, p120 

    Objective: Luteinizing hormone (LH) requirement in assisted reproductive treatment (ART) cycles is still controversial. The objective of this study was to investigate the impact of providing LH activity with recombinant LH (rLH) on the oocyte and embryo quality in both GnRH agonist long and...

  • Direct ovarian effects and safety aspects of GnRH agonists and antagonists. Tarlatzis, B. C.; Kolibianakis, E. M. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p8 

    The wide application of gonadotrophin-releasing hormone (GnRH) analogues in assisted reproduction has raised concerns about their potential extra-pituitary actions. Although data from animal studies support the presence of ovarian GnRH receptors and of direct ovarian effects of GnRH analogues,...

  • GnRH Antagonist Produces Similar Results as GnRH-Agonist.  // Fertility Weekly;12/6/2010, p8 

    The article presents a study which aims to determine the effectiveness of luteinizing hormone releasing hormone (GnRH) antagonist and luteinizing hormone releasing hormone (GnRH) agonist protocol in polycystic ovary syndrome (PCOS) patients pretreated with oral contraceptive pill (OCP)....

  • The role of GnRH antagonists in assisted reproduction. Barri, Pedro N.; Martinez, Francisca; Coroleu, Buenaventura; Tur, Rosa // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p14 

    The different schemes of application of gonadotrophin-releasing hormone (GnRH) antagonists in ovarian stimulation protocols for assisted reproduction are reviewed. Starting from the initial schemes of single and/or multiple doses, the efficacy of GnRH antagonists in 'soft' protocols of ovarian...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics